866-997-4948(US-Canada Toll Free)

AntiCancer, Inc. - Product Pipeline Review - 2014

Published By :

Global Markets Direct

Published Date : Oct 2014

Category :


No. of Pages : 24 Pages

AntiCancer, Inc. - Product Pipeline Review - 2014


Global Markets Directs, AntiCancer, Inc. - Product Pipeline Review - 2014, provides an overview of the AntiCancer, Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AntiCancer, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides brief overview of AntiCancer, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of AntiCancer, Inc.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the AntiCancer, Inc.s pipeline products

Reasons to buy

- Evaluate AntiCancer, Inc.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of AntiCancer, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the AntiCancer, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of AntiCancer, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of AntiCancer, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of AntiCancer, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
AntiCancer, Inc. Snapshot 4
AntiCancer, Inc. Overview 4
Key Information 4
Key Facts 4
AntiCancer, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
AntiCancer, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Combination Treatment Modalities 9
AntiCancer, Inc. - Pipeline Products Glance 10
AntiCancer, Inc. - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Discovery Products/Combination Treatment Modalities 11
AntiCancer, Inc. - Drug Profiles 12
ONCase 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Salmonella typhimurium A1-R 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
adeno MET gene + selenomethionine 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
GFP-Bacterial MET Gene + selenomethionine 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Lipo-4MA 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
rHCYase 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
AntiCancer, Inc. - Pipeline Analysis 18
AntiCancer, Inc. - Pipeline Products by Target 18
AntiCancer, Inc. - Pipeline Products by Route of Administration 19
AntiCancer, Inc. - Pipeline Products by Molecule Type 20
AntiCancer, Inc. - Pipeline Products by Mechanism of Action 21
AntiCancer, Inc. - Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
Disclaimer 24

List of Tables
AntiCancer, Inc., Key Information 4
AntiCancer, Inc., Key Facts 4
AntiCancer, Inc. - Pipeline by Indication, 2014 6
AntiCancer, Inc. - Pipeline by Stage of Development, 2014 7
AntiCancer, Inc. - Monotherapy Products in Pipeline, 2014 8
AntiCancer, Inc. - Combination Treatment Modalities in Pipeline, 2014 9
AntiCancer, Inc. - Preclinical, 2014 10
AntiCancer, Inc. - Discovery, 2014 11
AntiCancer, Inc. - Pipeline by Target, 2014 18
AntiCancer, Inc. - Pipeline by Route of Administration, 2014 19
AntiCancer, Inc. - Pipeline by Molecule Type, 2014 20
AntiCancer, Inc. - Pipeline Products by Mechanism of Action, 2014 21

List of Figures
AntiCancer, Inc. - Pipeline by Top 10 Indication, 2014 6
AntiCancer, Inc. - Pipeline by Stage of Development, 2014 7
AntiCancer, Inc. - Monotherapy Products in Pipeline, 2014 8
AntiCancer, Inc. - Pipeline by Top 10 Molecule Type, 2014 20

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *